The novel approach of the medication represents a major development in the management of diabetes mellitus type 2. Unlike existing drugs, tirzepatide impacts two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide629592.jaiblogs.com/69107893/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment